Bendamustine Hydrochloride and Rituximab With or Without Bortezomib Followed by Rituximab With or Without Lenalidomide in Treating Patients With High-Risk Stage II, Stage III, or Stage IV Follicular Lymphoma
Clinical trial NCT01216683 · COMPLETED
Trial details
- NCT number
- NCT01216683
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-09
- Primary completion
- 2019-12-02
- Enrollment
- 289
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.